MARKET INTRODUCTION
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity.


MARKET DYNAMICS
The small molecules drugs discovery market is anticipated to grow in the forecast period owing to increasing drug discovery, increased use of these drugs in treatment of chronic diseases and development across the globe. However, the rising demand of innovative and effective therapies, preference for small molecules and growing number of contract research organizations are likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Small Molecules Drugs Discovery Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of small molecules drugs discovery market with detailed market segmentation by therapeutic area, process/phase and geography. The global small molecules drugs discovery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global small molecules drugs discovery market is segmented on the basis of therapeutic area and process/phase. Based on therapeutic area, the market is classified as oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology and other therapeutic areas. On the basis of process/phase, the market is divided into target ID/ validation, hit generation & selection, lead identification and lead optimization.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global small molecules drugs discovery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The small molecules drugs discovery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting small molecules drugs discovery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the small molecules drugs discovery market in these regions.





MARKET PLAYERS
The reports cover key developments in the small molecules drugs discovery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from small molecules drugs discovery market are anticipated to lucrative growth opportunities in the future with the rising demand for small molecules drugs discovery market in the global market. Below mentioned is the list of few companies engaged in the small molecules drugs discovery market.

The report also includes the profiles of key small molecules drugs discovery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Pfizer Inc.
- Bristol-Myers Squibb Company
- Merck KGaA, Darmstadt
- GlaxoSmithKline plc.
- AstraZeneca
- Johnson and Johnson Services, Inc.
- Gilead Sciences, Inc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International GmbH
- ALLERGAN